# Emi Gonzalez

> Emi Gonzalez is a seed investor at Ataraxia (Boston) backing Medical and Software. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Ataraxia](https://shizune.co/investors/profile/ataraxia-capital-partners)
- Location: Boston, United States
- Total investments: 2
- Last investment: Oct 2020
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/emilia-gonzalez-4b924b9a/
- Website: http://checkmatediabetes.com
- Facebook: https://www.facebook.com/emigonzalez19

Emi Gonzalez is a seed investor at Ataraxia in Boston focused on Medical and Software. Emi Gonzalez is the Investment Partner at Joyance Partners. She attended Harvard University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 50% |
| Software | 1 | 50% |
| Biopharma | 1 | 50% |
| Health Care | 1 | 50% |
| Life Science | 1 | 50% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Series A | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| BioAesthetics | BioAesthetics was founded in 2015 as a Tulane University spin-out with the mission to improve reconstruction options for breast cancer patients after they undergo mastectomies. The BioAesthetics’ initial product is a tissue-engineered nipple-areolar complex (NAC). This product will be provided to plastic and reconstructive surgeons as anoff-the-shelf ready, acellular, NAC graft. During the breast reconstruction phase, after a mastectomy, the surgeon would engraft the NAC graft in position onto the patient’s reconstructed breast. The patient’s body would then use this NAC graft as a building frame to regenerate their own NAC. This patent-pending product is currently in the pre-clinical phase. | $6.4M | Series A | Oct 05, 2020 |  |
| Dyad Medical | Dyad Medical develops software that automatically analyzes the content of cardiac and cardiovascular images. Its software applications support both treatment decision making in the clinic and analysis in research, enabling researchers to optimize observations and conclusions. It was founded in 2018 and headquartered in Boston, Massachusetts. | $3.5M | Seed | Oct 02, 2020 |  |

2 of 2 investments shown.

## Co-investors
- [Arizona Tech Investors](https://shizune.co/investors/profile/arizona-technology-investor-forum) — VC Fund, 1 deal together
- [FemHealth Ventures](https://shizune.co/investors/profile/femhealth-ventures) — VC Fund, 1 deal together
- [New Orleans BioFund](https://shizune.co/investors/profile/new-orleans-biofund) — VC Fund, 1 deal together
- [NO/LA Angel Network](https://shizune.co/investors/profile/no-la-angel-network) — VC Fund, 1 deal together
- [SOSV SF & NY (Fka IndieBio)](https://shizune.co/investors/profile/synbio-axlr8r) — VC Fund, 1 deal together
- [The Launch Place](https://shizune.co/investors/profile/the-launch-place) — VC Fund, 1 deal together

## About Ataraxia

VC Fund · Melbourne, Australia

Ataraxia is a banking company that offers a wide range of asset management and fund services.

1 contacts available at Ataraxia.

| Name | Title | Profile |
| --- | --- | --- |
| Emi Gonzalez | Investment Partner | https://shizune.co/investors/profile/emi-gonzalez |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Emi Gonzalez invest in?

Emi Gonzalez invests primarily in Medical, Software and Biopharma startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Emi Gonzalez last invest?

The most recent investment recorded for Emi Gonzalez closed in Oct 2020. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co